Clinical trial

Response of Cardiac Resynchronization Therapy Optimization With Ventricle to…

NCT00187200 · Abbott Medical Devices, Industry · Completed

Key facts

NCT number NCT00187200
Title Response of Cardiac Resynchronization Therapy Optimization With Ventricle to Ventricle Timing in Heart Failure Patients
Official title RESPONSE HF - Response of Cardiac Resynchronization Therapy Optimization With Interventricular (VV) Timing in Heart Failure Patients
Lead sponsor Abbott Medical Devices, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Heart Failure
Intervention type Device
Interventions Simultaneous VV Pacing, Sequential VV Pacing
Enrollment 816
Start date Jan 1, 2005
Primary completion Apr 1, 2010
Completion Apr 1, 2010
First posted Sep 16, 2005
Last update posted Feb 5, 2019
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • 10–99 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies